Mod­er­na’s mR­NA can­di­date picked for FDA’s Op­er­a­tion Warp Speed for rare dis­eases

Mod­er­na is join­ing an­oth­er Op­er­a­tion Warp Speed ini­tia­tive — this time, for rare dis­eases.

The biotech’s mR­NA can­di­date for a pro­tein and lipid me­tab­o­lism dis­or­der was …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER